Search results for alzheimer's

“People with at least one APOE4 allele are more susceptible to blood-brain barrier breakdown, which contributes to Alzheimer's disease development. APOE4 promotes the destruction of the blood-brain barrier by triggering the inflammatory cyclophilin A cascade.”

“Aging is the primary risk factor for many chronic diseases, including cancer, Alzheimer's disease, and Parkinson's disease. A person's epigenetic age correlates with their risk for developing these diseases, albeit weakly.”

“Approximately 25 percent of people living in the United States carry a genetic variant of this lipoprotein called APOE4, which is associated with higher circulating levels of LDL cholesterol and an increased risk for Alzheimer's disease. In this clip, Dr. Peter Attia discusses the role of the APOE4 gene variant and the associated risk for Alzheimer’s disease and cardiovascular disease.”

“People carrying the apolipoprotein E4 (APOE4) gene are at a higher risk of developing Alzheimer's disease and can have more brain vascular problems despite being cognitively normal.”

“For example, hypertension alters the structure of cerebral blood vessels and impairs adequate blood flow to the brain. Poor cerebral blood flow is commonly observed in mice and humans and may contribute to impaired amyloid-beta clearance, thereby accelerating the progression of Alzheimer’s disease.”

Dr. Rhonda Patrick discusses glucosamine and Alzheimer's, blood flow restriction, beta-glucan fiber, creatine, collagen, red light therapy, and curcumin.

“Many lifestyle behaviors can mitigate risk, especially sleep hygiene, which provides an opportunity to rid the brain of toxic metabolic byproducts that can contribute to Alzheimer's disease risk.”

“Early biomarkers of vascular dysfunction, such as soluble platelet-derived growth factor receptor-beta (sPDGFR-β), can help identify individuals at risk for developing Alzheimer's disease. These biomarkers are being validated on high-throughput platforms for large-scale testing.”

“Biomarkers of blood-brain barrier dysfunction can be measured before other pathological hallmarks of Alzheimer's disease, including amyloid plaques and tau tangles.”

“Approximately 25 percent of people in the United States – roughly 75 million people – carry a genetic variant of this lipoprotein called APOE4, which is associated with higher circulating levels of LDL cholesterol and an increased risk for Alzheimer's disease.”